Applying sputum as a diagnostic tool in pneumonia - limited yield, minimal impact on treatment decisions

S. Ewig, M. Schlochtermeier, N. Göke, M. S. Niederman (Bonn, Wesseling, Germany; Mineola, United States Of America)

Source: Annual Congress 2001 - Community-acquired pneumonia: from diagnosis to discharge
Session: Community-acquired pneumonia: from diagnosis to discharge
Session type: Oral Presentation
Number: 3390
Disease area: Respiratory infections

Congress or journal article abstract

Abstract

OBJECTIVES. We evaluated the role of sputum in the management of patients with CAP in a primary care hospital without microbiological laboratory facilities.
DESIGN AND INTERVENTIONS. Regular collection of sputum samples, Gram staining in a local laboratory, and mailing of samples for culture in a commercial laboratory were implemented as a diagnostic strategy.
PATIENTS. 116 consecutive patients with CAP were prospectively recorded during a 12 month period.
RESULTS. 42/116 (36%) patients were capable of producing a sputum sample. Age > 75 years (OR 0.4, 95% CI 0.18 - 0.93) and prior ambulutory antimicrobial treatment (OR 3.2, 95% CI 1.2 - 8.4) were independent predictors of sputum production. A delay in collection and processing of sputum samples was present in 31% and 39%, respectively. The former yielded an increased number of GNEB and nonfermenters (44% vs 7%, p = 0.056). The latter was associated with an increase of Candida spp. isolates (80% versus 6%, p = 0.003). The overall diagnostic yield was low (10 of 116, 8%) due to a limited number of valid samples (n = 23 of 42, 55%) and of definitely or probably positive samples in Gram stain and culture (n = 10 of 42, 24%). Prior ambulatory antimicrobial treatment was associated with a reduction in diagnostic yield (14% vs 56%, p = 0.09). The impact of diagnostic results on antimicrobial treatment decisions was minimal, with directed antimicrobial treatment according to diagnostic results in only one patient.
CONCLUSIONS. We conclude that in this setting representative for primary care hospitals in Germany, sputum failed to be useful and should not form part of an initial management approach for the selection of initial antimicrobial treatment.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Ewig, M. Schlochtermeier, N. Göke, M. S. Niederman (Bonn, Wesseling, Germany; Mineola, United States Of America). Applying sputum as a diagnostic tool in pneumonia - limited yield, minimal impact on treatment decisions. Eur Respir J 2001; 16: Suppl. 31, 3390

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The standardised treatment of pulmonary TB: outcomes, problems and suggestions
Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties
Year: 2005


What is the value of multiple sputum cultures in the routine investigation of community acquired pneumonia (CAP)?
Source: Eur Respir J 2003; 22: Suppl. 45, 151s
Year: 2003

We provided patients with patients oriented diagnosis and treatment advice from their lung assessments using an algorithm. It was feasible and in general well appreciated by our patients
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016


The role of inhaled antibiotics in bronchial infection
Source: Eur Respir Monogr 2013; 60: 120-126
Year: 2013


Clinical efficacy data for new diagnostic tool for the selection of the most effective antibiotics for patients with cystic fibrosis
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting
Source: International Congress 2016 – Airway biomarkers
Year: 2016


The diagnostic yield of the pneumococcal urinary antigen test in clinical practice and its impact on antibiotic therapy
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011


Is PPD still a screening diagnostic tool for tuberculosis alone, or for something else also?
Source: Eur Respir J 2006; 28: Suppl. 50, 21s
Year: 2006

Quality-indicators and prognostics in CAP in three populations
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


External validation of a decision support system for respiratory primary care patients: A study of diagnostic accuracy
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015


Community use of digital auscultation to improve diagnosis of childhood pneumonia in low resource setting
Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children
Year: 2020

The impact of different reference standards when estimating the accuracy of tests for diagnosing asthma
Source: International Congress 2018 – Primary care management of asthma
Year: 2018

The clinical value of initial microbiological studies in exacerbations of COPD is questionable and not affected by antibiotics prior to hospitalization
Source: Eur Respir J 2001; 18: Suppl. 33, 541s
Year: 2001

Sputum: ready for clinical applications?
Source: Annual Congress 2005 - PG6 - New and old methodologies to assess pathobiological markers in the lung and airways: from research into clinical practice
Year: 2005

IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012


The influence of modern microbiological methods on the antibiotic treatment of pneumonia in children
Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes
Year: 2018


Treatment step-up strategy based on sputum eosinophil levels does not yield any better results than standard strategy
Source: Eur Respir J 2005; 26: Suppl. 49, 574s
Year: 2005

TB education - a method for better therapeutic results
Source: Eur Respir J 2002; 20: Suppl. 38, 548s
Year: 2002

First steps at implementing value based healthcare internationally in sarcoidosis: comparing outcomes.
Source: International Congress 2017 – Respiratory epidemiology: from sarcoidosis to respiratory infections and tuberculosis
Year: 2017


COPD detected with screening: impact on patient management and prognosis
Source: Eur Respir J 2014; 44: 1571-1578
Year: 2014